News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Hervé Lilliu

Advertisement

Articles by Hervé Lilliu

Four Takeaways from the Zolgensma Pricing Storm

ByHervé Lilliu
August 10th 2019

Pharmaceutical Executive

Four takeaway messages from the Zolgensma pricing storm

Advertisement

Latest Updated Articles

  • Four Takeaways from the Zolgensma Pricing Storm
    Four Takeaways from the Zolgensma Pricing Storm

    August 10th 2019



Advertisement
Advertisement

Trending on PharmExec

1

Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report

2

Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees

3

Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty

4

Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees

5

What Unexpected Costs do GLP-1 Patients Face?

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us